Clinical Trial Update: Evaluation Of SB-751689 Administered At Supratherapeutic Dose Levels In Healthy Adult Subjects. [Phase 1]

View source ↗

Summary

A Phase 1 study by GlaxoSmithKline evaluated SB-751689 at supratherapeutic doses in healthy adults to assess safety and pharmacology in the context of osteoporo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• SB-751689 (SB-751689)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED